Wenn Sie das Fenster schließen, wird Ihre Konfiguration nicht gespeichert, es sei denn, Sie haben Ihren Artikel in die Bestellung aufgenommen oder zu Ihren Favoriten hinzugefügt.
Klicken Sie auf OK, um das MILLIPLEX® MAP-Tool zu schließen oder auf Abbrechen, um zu Ihrer Auswahl zurückzukehren.
Wählen Sie konfigurierbare Panels & Premixed-Kits - ODER - Kits für die zelluläre Signaltransduktion & MAPmates™
Konfigurieren Sie Ihre MILLIPLEX® MAP-Kits und lassen sich den Preis anzeigen.
Konfigurierbare Panels & Premixed-Kits
Unser breites Angebot enthält Multiplex-Panels, für die Sie die Analyten auswählen können, die am besten für Ihre Anwendung geeignet sind. Unter einem separaten Register können Sie das Premixed-Cytokin-Format oder ein Singleplex-Kit wählen.
Kits für die zelluläre Signaltransduktion & MAPmates™
Wählen Sie gebrauchsfertige Kits zur Erforschung gesamter Signalwege oder Prozesse. Oder konfigurieren Sie Ihre eigenen Kits mit Singleplex MAPmates™.
Die folgenden MAPmates™ sollten nicht zusammen analysiert werden: -MAPmates™, die einen unterschiedlichen Assaypuffer erfordern. -Phosphospezifische und MAPmate™ Gesamtkombinationen wie Gesamt-GSK3β und Gesamt-GSK3β (Ser 9). -PanTyr und locusspezifische MAPmates™, z.B. Phospho-EGF-Rezeptor und Phospho-STAT1 (Tyr701). -Mehr als 1 Phospho-MAPmate™ für ein einziges Target (Akt, STAT3). -GAPDH und β-Tubulin können nicht mit Kits oder MAPmates™, die panTyr enthalten, analysiert werden.
.
Bestellnummer
Bestellinformationen
St./Pkg.
Liste
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Wählen Sie bitte Spezies, Panelart, Kit oder Probenart
Um Ihr MILLIPLEX® MAP-Kit zu konfigurieren, wählen Sie zunächst eine Spezies, eine Panelart und/oder ein Kit.
Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Spezies
Panelart
Gewähltes Kit
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
96-Well Plate
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
Weitere Reagenzien hinzufügen (MAPmates erfordern die Verwendung eines Puffer- und Detektionskits)
Menge
Bestellnummer
Bestellinformationen
St./Pkg.
Listenpreis
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Platzsparende Option Kunden, die mehrere Kits kaufen, können ihre Multiplex-Assaykomponenten in Kunststoffbeuteln anstelle von Packungen erhalten, um eine kompaktere Lagerung zu ermöglichen.
Dieser Artikel wurde zu Ihren Favoriten hinzugefügt.
Das Produkt wurde in Ihre Bestellung aufgenommen
Sie können nun ein weiteres Kit konfigurieren, ein Premixed-Kit wählen, zur Kasse gehen oder das Bestell-Tool schließen.
A highly sensitive and specific kit for detection of MMP-13 from human samples, including serum, synovial fluid, and cell culture supernatant. Recognizes both the latent and active forms of MMP-13, however exhibits 10-fold higher sensitivity towards the active than the latent form of MMP-13. Does not recognize MMP-1, MMP-2, MMP-3, MMP-8, or MMP-9.
• Pipettes with disposable tips (100 µl, 500 µl and 1 ml), a multi-channel pipette (100-200 µl) • Distilled or deionized water • Horizontal orbital microplate shaker • Microplate reader capable of measuring absorbance at 450 nm • Squirt bottle or automated microplate washer • 500 ml graduated cylinder
References
References
Bluteau G., et al. 2001. Biochim. Biophys. Acta1526, 147. Brew, K., et al. 2000. Biochim Biophys. Acta1477, 267. Pendas A.M., et al. 2000. Clin. Chim. Acta291, 137. Nagase, H., and Woessner, F. Jr. 1999. J. Biol. Chem.274, 21491. Westhoff C.S., et al. 1999. Arthritis Rheum.42, 1517. Knauper V., et al. 1996. J. Biol. Chem.271, 17124.
Product Information
Detection method
Colorimetric
Form
96 Tests
Format
96-well plate
Kit contains
Coated 96-Well Plate, Assay Buffer, Wash Buffer Concentrate, Standard, Serum Standard Diluent, Detection Buffer, Biotinylated Antibody, Conjugate Solution, TMB Substrate, Stop Solution, and a user protocol.
Applications
Biological Information
Assay range
32 - 2000 pg/ml
Assay time
~5 hours
Sample Type
Serum, synovial fluid, tissue culture supernatant
Species Reactivity
Human
Physicochemical Information
Sensitivity
7 pg/ml
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Intended use
The MMP-13 ELISA Kit is a non-isotopic immunoassay for the in vitro quantitation of latent and active human MMP-13 protein in body fluids such as serum and synovial fluids. Note: When analyzing pro-MMP-13 and active MMP-13 in parallel, the level of pro-MMP-13 must be ~10 times higher than the level of active MMP-13 in order to obtain a comparable signal.
Storage and Shipping Information
Ship Code
Blue Ice Only
Toxicity
Multiple Toxicity Values, refer to MSDS
Storage
+2°C to +8°C
Storage Conditions
All components of the kit can be stored in the refrigerator (4°C). Once reconstituted, the standard solution should be used immediately or stored at -20°C. The diluted Biotinylated Detection Antibody and diluted Conjugate Solution should be prepared freshly directly before use. When running a partial plate, only a suitable aliquot should be activated.
Avoid freeze/thaw
Avoid freeze/thaw
Do not freeze
Ok to freeze
Packaging Information
Transport Information
Supplemental Information
Kit contains
Coated 96-Well Plate, Assay Buffer, Wash Buffer Concentrate, Standard, Serum Standard Diluent, Detection Buffer, Biotinylated Antibody, Conjugate Solution, TMB Substrate, Stop Solution, and a user protocol.
Specifications
Global Trade Item Number
Bestellnummer
GTIN
QIA130
0
Documentation
MMP-13 ELISA Kit Analysenzertifikate
Titel
Chargennummer
QIA130
Literatur
Übersicht
Bluteau G., et al. 2001. Biochim. Biophys. Acta1526, 147. Brew, K., et al. 2000. Biochim Biophys. Acta1477, 267. Pendas A.M., et al. 2000. Clin. Chim. Acta291, 137. Nagase, H., and Woessner, F. Jr. 1999. J. Biol. Chem.274, 21491. Westhoff C.S., et al. 1999. Arthritis Rheum.42, 1517. Knauper V., et al. 1996. J. Biol. Chem.271, 17124.
All components of the kit can be stored in the refrigerator (4°C). Once reconstituted, the standard solution should be used immediately or stored at -20°C. The diluted Biotinylated Detection Antibody and diluted Conjugate Solution should be prepared freshly directly before use. When running a partial plate, only a suitable aliquot should be activated.
Intended use
The MMP-13 ELISA Kit is a non-isotopic immunoassay for the in vitro quantitation of latent and active human MMP-13 protein in body fluids such as serum and synovial fluids. Note: When analyzing pro-MMP-13 and active MMP-13 in parallel, the level of pro-MMP-13 must be ~10 times higher than the level of active MMP-13 in order to obtain a comparable signal.
Background
Matrix metalloproteinases (MMPs) comprise a family of secreted and membrane-bound endopeptidases that hydrolyze extracellular matrix proteins. Based on their preferred substrates and on structural features MMPs can be divided into collagenases, gelatinases, stromelysins, and membrane-type matrix metalloproteinases. The activity of these enzymes is tightly regulated by tissue inhibitors of metalloproteinases (TIMP). Collagenase 3 (MMP-13) is a secreted 452 amino acid protein that is released from cells as an inactive zymogen and activated extracellularly by removal of its propeptide. Cleavage of the 84 amino acid propeptide can be catalyzed by other MMPs such as MMP-2 and MMP-14, or by factors like plasmin. Under normal conditions, MMP-13 is expressed during embryogenesis (fetal bone development) and is present only at very low levels in adult tissue. However, this enzyme is reported to be involved in the development and metastasis of breast and lung carcinomas, chondrosarcomas and osteosarcomas, head and neck carcinomas, and some forms of skin cancer. Additionally, this enzyme plays an important role in degenerative bone diseases including osteoarthritis and rheumatoid arthritis.
Principles of the assay
The MMP-13 ELISA Kit provides a highly sensitive, specific, and quantitative determination of latent and active human MMP-13 in serum, synovial fluid, and cell culture supernatants.
This quantitative assay is based on a two-site sandwich format. A highly specific monoclonal antibody recognizing the MMP-13 is immobilized on the plate. MMP-13 is bound to the wells and other components of the sample are removed by aspiration and washing of the plate. Two steps using a secondary biotinylated antibody and a highly polymerized streptavidin-peroxidase conjugate detect the analyte. Excess antibody is removed by aspiration and washing after each detection step. The amount of peroxidase bound to each well is determined by the addition of TMB Substrate. The reaction is stopped by addition of Stop Solution and the resultant color is read in a microtiter plate reader at 450 nm. The concentration of MMP-13 in samples is determined by interpolation from the standard curve.
Materials provided
• Coated 96-Well Plate (Kit Compnent No. JA7710): The plate contains 6 x 16 strips coated with anti-MMP-13. The strips are ready to use. • Assay Buffer (Kit Component No. JA7711): Bottle contains a phosphate buffer with additives. Ready to use. • Wash Buffer Concentrate (Kit Compnent No. JA7712): Each bottle (total of 2 bottles) contains a buffer concentrate that has to be diluted 20 fold to get 500 ml Wash Buffer. • MMP-13 Standard (Kit Compnent No. JA7713): The vial contains lyophilized activated MMP-13 in Assay Buffer. It has to be reconstituted with 1 ml of distilled water prior to use to get a 20 ng/ml stock solution. • Serum Standard Diluent (Kit Compnent No. JA7714): This solution contains certified human serum in a buffer with additives. Ready to use. Warning: Component contains human serum! Wear eye, hand, face, and clothing protection when using this material! • Detection Buffer (Kit Compnent No. JA9210): This solution consists of phosphate buffer containing additives. • Biotinylated Antibody (Kit Compnent No. JA9211): This solution contains biotinylated monoclonal anti-procollagenase 3 antibody in a buffer with additives. Antibody has to be diluted 100-fold with Detection Buffer before use. • Conjugate Solution (Kit Compnent No. JA7717): This solution contains a highly polymeric streptavidin-peroxidase conjugate in stabilizer with preservatives. It has to be diluted 40-fold with Detection Buffer prior to use. • TMB Substrate (Kit Compnent No. JA7718): Bottle contains a TMB solution ready to use. • Stop Solution (Kit Compnent No. JA7719): Bottle contains 0.25 M H₂SO₄. Ready to use. See warning under Safety Warning and Precautions.
Materials Required but not provided
• Pipettes with disposable tips (100 µl, 500 µl and 1 ml), a multi-channel pipette (100-200 µl) • Distilled or deionized water • Horizontal orbital microplate shaker • Microplate reader capable of measuring absorbance at 450 nm • Squirt bottle or automated microplate washer • 500 ml graduated cylinder
Precautions and recommendations
• Stop solution contains 0.25 M sulphuric acid. Wear eye, hand, face, and clothing protection when using this material. • The Serum Standard Diluent contains human serum that has been tested negatively for HAV, HBV, HCV and HIV. Wear suitable protective clothing, such as laboratory overalls and gloves and observe caution when working with this material. • All chemicals should be considered as potentially hazardous. We therefore recommend that only those persons who have been trained in laboratory techniques handle this product and that it is used only in accordance with the principles of good laboratory practice. Wear suitable protective clothing, such as laboratory overalls, safety glasses, and gloves. Avoid contact with skin and eyes. In case of contact, wash immediately with water. • Allow samples and all reagents to equilibrate to room temperature (20-30°C) prior to performing the assay. This is an essential prerequisite for the TMB Substrate. • For the highly sensitive determination of collagenase-3 in serum or synovial fluid samples, use the Serum Standard Diluent to prepare the standard curve. • It is absolutely essential that all wells be washed thoroughly and uniformly. When washing is done by hand, use a squeeze bottle and ensure that all wells are completely filled and emptied at each step. • Use only reagents from the same lot for each assay. This is especially important when running more than one plate per sample group. • A separate standard curve must be run on each plate. • Mix all reagents thoroughly prior to use, avoiding foaming. • Keep the wells sealed with the foil except when adding reagents and during reading. • Any variation in the protocol can cause variation in binding. • The values obtained by the samples should be within the standard range. If this is not the case, dilute the sample and repeat the assay. • We take great care to ensure that this product is suitable for all validated sample types, as designated in this manual. However, it is possible that in some cases, high levels of interfering substances may cause unusual results. • Samples should not contain EDTA or other chelating reagents as they inhibit the assay.
Preparation
Serum:
• Serum samples may be stored at -80°C.
• Avoid freeze/thaw cycles.
• When the serum is stored at -80°C, it is absolutely necessary to mix the samples thoroughly prior to measuring.
• Dilute the serum samples 1:10 with Assay Buffer, depending on the possible concentration of the analyte. For measuring these dilutions use the standards prepared with Serum Standard Diluent.
• If you need samples with a dilution of more than 1:10, initially prepare a 1:10 dilution with Assay Buffer and do further dilution steps using Serum Standard Diluent. This is necessary to maintain a serum concentration of 10% in the sample.
Synovial Fluid:
• Centrifuge the collected synovial fluid for 15 min at 4000 x g or higher.
• The supernatant can be stored at -80°C.
• Avoid freeze/thaw cycles.
• When the synovial fluid was stored at -80°C, it is absolutely necessary to mix the samples thoroughly prior to measuring.
• Dilute the samples 1:10 or more with Assay Buffer, depending on the possible concentration of the analyte. For measuring these samples, use the standards prepared with Serum Standard Diluent.
• If you need samples with a dilution of more than 1:10, initially prepare a 1:10 dilution with Assay Buffer and do further dilution steps using Serum Standard Diluent.
• It is important to note that the recovery of MMP-13 in synovial fluid is only 50% or less (see table 5).
Tissue culture supernatant
• Centrifuge the samples to remove any particles.
• The supernatants can be stored at -80°C.
• Avoid freeze/thaw cycles.
• Dilute the samples 1:3 or more with Assay Buffer, depending on the possible concentration of the analyte. For measuring diluted samples use the standards prepared with Assay Buffer
Note: Fetal or neonatal calf serum may contain Collagenase 3. Always measure your culture media as background controls!
Reagent preparation
It is absolutely necessary to equilibrate all reagents to room temperature (1 h incubation on the bench) prior to use in order to prevent margin effects. Use either distilled or deionized water for the reconstitution of the standard and for the dilution of the wash buffer concentrate. Always seal the plates with the provided foil during incubation.
• Assay Buffer: After equilibration to room temperature, the buffer is ready to use.
• Wash Buffer: Dilute the contents of the bottle (25 ml) to 500 ml with distilled or deionized water. Thoroughly wash the stock bottle to ensure that the entire contents are used.
• Standard: Add 1 ml distilled or deionized water to the standard tube (yellow lid) and allow the contents to dissolve for 30 min. Gently mix, but avoid foaming of the reagent!
• Serum Standard Diluent: After equilibration to room temperature, the reagent is ready to use.
• Detection Buffer: After equilibration to room temperature, the reagent is ready to use.
• Biotinylated Antibody: Dilute Biotinylated Antibody 100-fold with Detection Buffer. For the whole plate, add 120 µl from the antibody solution tube (red lid) to 12 ml Detection Buffer. When running half a plate, add 60 ml antibody solution to 6 ml Detection Buffer.
• Conjugate Solution: Dilute the provided Conjugate Solution 40-fold with Detection Buffer. For the whole plate, add 300 µl of the conjugate tube (blue lid) to 12 ml Detection Buffer. When running half a plate, add 150 µl of the conjugate to 6 ml of Detection Buffer.
• Substrate and Stop Solution: After equilibration to room temperature, the reagents are ready to use.
Preparation of Standards with Assay Buffer
(For tissue culture supernatants)
1. Label 7 tubes with 32, 63, 125, 250, 500, 1000, and 2000 pg/ml.
2. Pipette 900 µl of Assay Buffer into the 2000 pg/ml tube, the remaining tubes pipette 500 µl of Assay Buffer.
3. Pipette 100 µl of the stock standard (20 ng/ml) into the 2000 pg/ml tube and mix thoroughly.
4. Pipette 500 µl of the 2000 pg/ml standard into the tube labeled with 1000 pg/ml and mix thoroughly.
5. Repeat this dilution procedure with the other standard tubes.
6. The blank value (0 pg/ml) is obtained by using simple Assay Buffer.
7. The stock solution is not part of the standard curve and can be stored at -20°C.
Preparation of standards with Serum Standard Diluent
(For the highly sensitive measurement of serum and synovial fluid samples)
1. Label 7 tubes with 32, 63, 125, 250, 500, 1000, and 2000 pg/ml.
2. Pipette 900 µl of Serum Standard Diluent into the 2000 pg/ml tube, in the remaining tubes pipette 500 µl of Serum Standard Diluent.
3. Pipette 100 µl of the stock standard (20 ng/ml) into the 2000 pg/ml tube and mix thoroughly.
4. Pipette 500 µl of the 2000 pg/ml standard into the tube labeled with 1000 pg/ml and mix thoroughly.
5. Repeat this dilution procedure with the other standard tubes.
6. The blank value (0 pg/ml) is obtained by using Serum Standard Diluent.
7. The stock solution is not part of the standard curve and can be stored at -20°C.
Detailed protocol
1. Prepare reagents and standards as described in the sections above. For assessing serum samples, prepare the standard using the Serum Standard Diluent. NOTE: It is necessary to equilibrate the reagents to room temperature before use. 2. Prepare the unknown samples as described above by appropriate dilution with Assay Buffer. 3. Prepare the 96-well plate by inserting the required amount of wells into the frame. Note that you need 16 wells for the standard curve. 4. Pipette 100 µl of the reconstituted standards in duplicate in the wells using a clean pipette tip for each standard. Assay Buffer serves as zero blank. 5. Pipette 100 µl of the prepared unknown samples in duplicate into the wells. 6. Seal the plate with the provided plate sealer and incubate on a shaker at room temperature for exactly 120 min. 7. Aspirate and wash the wells 4 times with Wash Buffer. Take care that all wells are completely filled and emptied at each wash. 8. Blot the plate on paper towels to remove residual fluid from the plate. 9. Add 100 µl of diluted Biotinylated Antibody into each well. 10. Seal the plate and incubate on a shaker at room temperature for exactly 90 min. 11. Aspirate and wash the wells 4 times with Wash Buffer. Take care that all wells are completely filled and emptied at each wash. 12. Blot the plate on paper towels to remove residual fluid from the plate 13. Add 100 µl of diluted Conjugate Solution into each well. 14. Seal the plate with the provided foil and incubate on a shaker at room temperature for exactly 30 min. 15. Aspirate and wash the wells 6 times with Wash Buffer. Take care that all wells are completely filled and emptied at each wash. 16. Blot the plate on paper towels to remove residual fluid from the plate. 17. Add 100 µl of Substrate Solution to each well. 18. Seal the plate with foil provided and incubate in the dark at room temperature for exactly 15 min. 19. Stop the reaction by adding 100 µl of Stop Solution to each well. 20. Read the plate at 450 nm (540, 570 or 620 nm reference filter) within 30 min. Note: Reading of the plate without reference may yield higher absorbances and thus may be less accurate.
Calculations
Calculations and Evaluation of Results
The calculation is illustrated using representative data: the assay data should be similar to that shown in Table 1.
1. Calculate the average absorbance for each set of standard wells.
2. A standard curve is generated by plotting the mean absorbance (y axis) against pg/ml standard (x-axis, Figure 1).
3. The pg/ml values of the samples can be read directly from the graph or calculated by the regression coefficients.
4. Multiply the calculated pg/ml values by the dilution factor of the samples.
Assay characteristics and examples
Table 1: Typical Assay Data
Figure 1: Standard Curve
Prepared with Assay Buffer.
Sensitivity
7 pg/ml
Sensitivity Notes
The sensitivity, defined as two standard deviations above the concentration mean of the calculated concentrations of 48 blank replicates was determined. The sensitivity was determined as 7 pg/ml.
Assay Range
32 - 2000 pg/ml
Precision
Table 2: Intra-assay precision in Assay Buffer (Precision in Serum Standard Diluent is si
Intra-assay precision was measured by assaying four control samples twenty times on one plate.
Table 3: Inter-assay precision in Assay Buffer (Precision in Serum Standard Diluent is si
The inter-assay variation was measured by assaying four control samples 16 times on different plates.
Table 4: Precision Profile
The precision profile was calculated as % CV from the mean and standard deviation of absorbance for each standard. The results for the determination in Assay Buffer are shown in Table 4.
Recovery
Table 5: Recovery
The recovery of MMP-13 standard spiked to levels throughout the range of the assay in various matrix types diluted down to 1:10 is shown in Table 5.
Linearity
Table 6: Linearity
The following samples were measured after dilution with Assay Buffer to assess linearity of the assay.
Specificity
The assay recognizes the activated form of MMP-13. It does not recognize the latent or activated forms of MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, or the catalytic domain of MT-1 MMP, MT-2 MMP, MT-3 MMP, MT-4 MMP, or MT-5 MMP. High concentrations of latent MMP-13 may contribute to absorbance values measured in the assay. When present at equal concentrations, latent MMP-13 yields about 1/10 the absorbance value of active MMP-13.
Protocol Summary
Figure 2: Protocol Summary
Registered Trademarks
Calbiochem® is a registered trademark of EMD Chemicals, Inc. Interactive Pathways™ is a trademark of EMD Chemicals, Inc.